Skip to main content
letter
. 2017 Sep 1;31(11):2523–2525. doi: 10.1038/leu.2017.242

Figure 1.

Figure 1

(a) Cumulative incidence of relapse and non-relapse mortality. (b) Overall survival. (c) Relapse-free survival. Kaplan–Meier curves are shown for all patients enrolled and calculated from the first dose of panobinostat. Symbols represent censoring times.